Elevance Health Analyst Ratings
TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Elevance Health (ELV) Receives a Buy From Truist Financial
Elevance Health Analyst Ratings
Deutsche Bank Adjusts Price Target on Elevance Health to $565 From $558, Maintains Buy Rating
Elevance Health Maintains Strong Outlook Amidst Medicaid Pressures With Outperform Rating Reiterated
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)
TD Cowen Reaffirms Their Buy Rating on Elevance Health (ELV)
Elevance Health Analyst Ratings
Elevance Health Analyst Ratings
Elevance Health (ELV) Receives a Buy From Barclays
Elevance Health Analyst Ratings
Elevance Health Analyst Ratings
Elevance Health Analyst Ratings
Elevance Health Analyst Ratings
Elevance Health Analyst Ratings
Wells Fargo Keeps Their Buy Rating on Elevance Health (ELV)
Elevance Health Analyst Ratings